Drug Shortage Report for XIIDRA
Report ID | 228910 |
Drug Identification Number | 02471027 |
Brand name | XIIDRA |
Common or Proper name | XIIDRA 50MG/ML CONTAINER 02ML (12X5) |
Company Name | BAUSCH & LOMB INC |
Market Status | MARKETED |
Active Ingredient(s) | LIFITEGRAST |
Strength(s) | 5% |
Dosage form(s) | SOLUTION |
Route of administration | OPHTHALMIC OPHTHALMIC |
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
Additional packaging sizes | 12 X 5 |
ATC code | S01XA |
ATC description | |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | 2024-05-28 |
Actual start date | 2024-05-28 |
Estimated end date | 2024-06-03 |
Actual end date | 2024-06-03 |
Shortage status | Resolved |
Updated date | 2024-06-05 |
Company comments | DISRUPTION IN DISTRIBUTION OF THE DRUG |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1400 N GOODMAN STREET ROCHESTER, NEW YORK UNITED STATES 14609 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2024-06-05 | French | Compare |
v5 | 2024-06-05 | English | Compare |
v4 | 2024-05-29 | English | Compare |
v3 | 2024-05-28 | French | Compare |
v2 | 2024-05-28 | English | Compare |
v1 | 2024-05-28 | English | Compare |
Showing 1 to 6 of 6